Skip to content

   Pharma Publications

Neuropsychopharmacology
  • The Cognitive–Affective Social Processing and Emotion Regulation (CASPER) model
    Published on 2025-09-04
    1 year ago
  • Role of β-Arrestin 2 in the antinociceptive and side effect profile of morphine and the novel mu opioid receptor agonists, kurkinorin and kurkinol
    Published on 2025-09-03
    1 year ago
  • Innovation with rigor in personalized medicine: back to the basics
    Published on 2025-09-03
    1 year ago
  • Lasting effects of oral contraceptives on fear responses to a safe context
    Published on 2025-08-30
    1 year ago
  • Considerations for conducting developmental neuroimaging research on mental health topics
    Published on 2025-08-30
    1 year ago
  • Anxiety and depression in emerging adults: The STAND program as a model of scalable screening and intervention
    Published on 2025-08-29
    1 year ago
  • Maternal separation disrupts noradrenergic control of adult coping behaviors
    Published on 2025-08-28
    1 year ago
« Previous 1 … 49 50 51 52 53 … 143 Next »
Journal of Psychopharmacology
  • Adult rat ultrasonic vocalizations and reward: Effects of propranolol and repeated cocaine administration
    Published on 2024-08-12
    2 years ago
  • Insomnia and the effect of zolpidem-extended-release on the sleep items of the Hamilton Rating Scale for Depression in outpatients with depression, insomnia, and suicidal ideation: Relationship to patient age
    Published on 2024-08-09
    2 years ago
  • Impact of childhood adversity on acute subjective effects of stimulant and opioid drugs: Evidence from placebo-controlled studies in healthy volunteers
    Published on 2024-08-09
    2 years ago
  • Re-visiting the association between antidepressant use and the risk of lung cancer
    Published on 2024-08-09
    2 years ago
  • Combining bioinformatics, network pharmacology and artificial intelligence to predict the target genes of S-ketamine for treating major depressive disorder
    Published on 2024-08-09
    2 years ago
  • Evidence-based guidelines for the interpretation of the 9-item Concise Health Risk Tracking – Self-Report (CHRT-SR9) measure of suicidal risk
    Published on 2024-08-09
    2 years ago
  • Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatment
    Published on 2024-08-08
    2 years ago
« Previous 1 … 49 50 51 52 53 … 154 Next »
European Neuropsychopharmacology
  • Taking uncertainty in the assessment of response into account: An advanced guideline for computing responder rates in clinical trials
    Published on 2024-04-21
    2 years ago
  • Schizophrenia patients are not benefiting from worldwide improvements in life expectancy
    Published on 2024-04-21
    2 years ago
  • Cognitive screening in bipolar disorder
    Published on 2024-04-21
    2 years ago
  • Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions
    Published on 2024-04-21
    2 years ago
  • Pre-existing chronic physical morbidity and excess mortality in people with bipolar disorder: A population-based cohort study in 2008–2018
    Published on 2024-04-21
    2 years ago
  • The role of anxiety and insomnia in the relationship between COVID-19 perseverative cognition and depression: Parallel and serial mediation analyses
    Published on 2024-04-21
    2 years ago
  • Rare variants and clozapine: Reply
    Published on 2024-04-21
    2 years ago
« Previous 1 … 49 50 51 52 53 … 170 Next »

   Pharma Pub